According to the founder Demis Hasabis, Google’s parent’s parent company’s Alphabet’s umbrella, Isomolfick Love’s, plans to start clinical trials for the first AI design drug by the end of 2025. Hasabis, a lecture at the World Economic Forum, said, as reported by the Financial Times, it has been targeting major diseases, such as tumor, cardiology, and neurodetics.
Please read this as well
Collaboration with Irillilly and Novartis
The company, which spinned out of Google Deepmind in 2021, aims to use artificial intelligence to reduce the timeline of pharmaceutical development, which had previously been 5 to 10 years, to 10 times. According to the report, ISOMORPHIC LABS cooperates in the pharmaceutical company Eli Lilly and Novartis and six pharmaceutical development programs.
Project Astra: AI Assistant
Hasabis, the highest executive officer of Google Deepmind, has stated that the company’s Prototype AI Assistant, known as Project Astra, will be provided to consumers this year. According to the report, he has a “billions of billions” within three years, stating the future in the near future “negotiating with vendors and customers.” He said that this development would need to be reconsidered by the web itself.
However, in the development of general -purpose artificial intelligence (AGI), Hasabis warned of further attention and cooperation among major AI developers, and warning the possibility of abuse by malicious people.
Threat to human civilization
He has warned that the technology may threaten human civilization if the technology is unable to control or “for harmful purposes by bad guys … for harmful purposes”.
According to Hasabis, Google Deepmind’s final goal is to create general -purpose artificial intelligence, a system that can demonstrate all human cognitive abilities. Despite the fact that it is close to the social media, it has been added that it is true. It took 5 to 10 years to realize AGI.
Please read this as well: Google promotes AI education to change the world story: report
According to the report, Hasabis said, “If something is possible and valuable, people will do it.” “With the advent of AI, the stage has already passed. It cannot be returned to the bottle, so we must strive to send it to the world in a safe way as possible.”